Bambusa Therapeutics, Inc. — Form 4
Filed November 2, 2026 · analyzed by the Insider Agent
4
▲ Likely positive
significance 68/100
What the filing says
Director Jeggle Helmut Wolfgang (BBTX) bought 5.1M shares (~$6.0M) on the open market (36% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating
Open-market insider purchase — historically a bullish signal.
See more from November 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.